2012
The Surgical Treatment of Breast Cancer in the Elderly: A Single Institution Comparative Review of 5235 Patients with 1028 Patients ≥70 years
Kaur P, Santillan A, McGuire K, Turaga K, Shamehdi C, Meade T, Ramos D, Mathias M, Parbhoo J, Davis M, Khakpour N, King J, Balducci L, Cox C. The Surgical Treatment of Breast Cancer in the Elderly: A Single Institution Comparative Review of 5235 Patients with 1028 Patients ≥70 years. The Breast Journal 2012, 18: 428-435. PMID: 22957995, DOI: 10.1111/j.1524-4741.2012.01272.x.Peer-Reviewed Original ResearchConceptsBreast-conserving surgeryDuctal carcinoma in situSurgical management of breast cancerManagement of breast cancerYears of ageBreast cancerInvasive carcinomaSurgical managementElderly womenSurgical treatment of breast cancerBreast-conserving surgery rateTreatment of breast cancerExtent of surgeryCarcinoma in situStandard surgical procedureMoffitt Cancer CenterBreast cancer treatmentDemographics of patientsConservative surgeryMastectomy ratesOperative mortalityRetrospective reviewSurgical mortalitySurgical treatmentStandard treatment
2011
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer
Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer. Annals Of Surgical Oncology 2011, 19: 1508-1516. PMID: 22193884, DOI: 10.1245/s10434-011-2108-2.Peer-Reviewed Original ResearchConceptsNeoadjuvant systemic therapyPrimary breast cancerBreast cancerSystemic therapyBreast-conserving surgery rateLarge adjuvant trialsPathologic complete responseInflammatory breast cancerNew therapeutic regimensIntermediate end pointsInternational Consensus ConferenceClinical research groupAdjuvant trialsNew regimensPathologic responseComplete responseSurgery ratesTherapeutic regimensConsensus conferenceEnd pointTherapyCancerTrialsRegimensPanel of representatives
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply